Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CDX-301 |
Trade Name | |
Synonyms | Mobista|CDX 301|CDX301 |
Drug Descriptions |
Mobista (CDX-301) is a recombinant Flt3 ligand that binds to and activates the Flt3 receptor, potentially leading to proliferation of immune precursor cells (PMID: 25915810). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C1714 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CDX-1140 + CDX-301 | CDX-1140 CDX-301 | 0 | 3 |
CDX-1140 + CDX-301 + Pegylated liposomal doxorubicin | CDX-1140 CDX-301 Pegylated liposomal doxorubicin | 0 | 1 |
CDX-1140 + CDX-301 + Poly ICLC | CDX-1140 CDX-301 Poly ICLC | 0 | 1 |
CDX-301 | CDX-301 | 0 | 3 |
CDX-301 + INO-5151 + Nivolumab | CDX-301 INO-5151 Nivolumab | 0 | 1 |
CDX-301 + Nivolumab + Poly ICLC | CDX-301 Nivolumab Poly ICLC | 0 | 2 |
CDX-301 + Pembrolizumab | CDX-301 Pembrolizumab | 0 | 1 |
CDX-301 + Pembrolizumab + Poly ICLC | CDX-301 Pembrolizumab Poly ICLC | 0 | 1 |
CDX-301 + PGV 001 + Poly ICLC | CDX-301 PGV 001 Poly ICLC | 0 | 1 |
CDX-301 + Poly ICLC | CDX-301 Poly ICLC | 0 | 1 |